C-N Bond-Linked Conjugates of Dibenz[b,f][1,4]oxazepines with 2-Oxindole

Xinglong Xing; Jinlong Wu; Jialu Luo; Wei-Min Dai

doi:10.1055/s-2006-948172

LETTER

C-N Bond-Linked Conjugates of Dibenz[b,f][1,4]oxazepines with 2-Oxindole

Xinglong Xing^a, Jinlong Wu^a, Jialu Luo^a, Wei-Min Dai*^a,b
^a Laboratory of Asymmetric Catalysis and Synthesis, Department of Chemistry, Zhejiang University, Hangzhou 310027, P. R. of China
Fax: +86(571)87953128; e-Mail: chdai@zju.edu.cn;
^b Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, P. R. of China
Fax: +85223581594; e-Mail: chdai@ust.hk;

Abstract

Alle Artikel dieser Rubrik

Abstract

An expeditious synthesis of highly functionalized dibenz[b,f][1,4]oxazepin-11(10H)-ones and dibenz[b,f][1,4]-oxazepine-11(10H)-carboxamides has been established via microwave-assisted one-pot U-4CR and intramolecular O-arylation. A Pd-catalyzed intramolecular amidation was successfully performed under microwave irradiation to furnish the novel conjugates of dibenz[b,f][1,4]oxazepin-11(10H)-ones with a 2-oxindole linked through a C-N single bond.

Key words

U-4CR - microwaves - heterocycles - palladium - lactams

Volltext

Referenzen

References and Notes

1a Klunder JM. Hargrave KD. West M. Cullen E. Pal K. Behnke ML. Kapadia SR. McNeil DW. Wu JC. Chow GC. Adams J. J. Med. Chem. 1992, 35: 1887

1b Merluzzi VJ. Hargrave KD. Labadia M. Grozinger K. Skoog M. Wu JC. Shih C.-K. Eckner K. Hattox S. Adams J. Rosenthal AS. Faanes R. Eckner RJ. Koup RA. Sullivan JL. Science 1990, 250: 1411

1c Nagarajan K. J. Indian Chem. Soc. 1997, 74: 831

2a Nagarajan K. David J. Grewal RS. Govindachari TR. Ind. J. Experim. Bio. 1974, 12: 217

2b Nagarajan K. David J. Bhat GA. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1985, 24: 840

2c Nagarajan K. David J. Kulkarni YS. Hendi SB. Shenoy SJ. Upadhyaya P. Eur. J. Med. Chem. Chim. Ther. 1986, 21: 21

3 Li R. Farmer PS. Wang J. Boyd RJ. Cameron TS. Quilliam MA. Walter JA. Howlett SE. Drug Des. Discov. 1995, 12: 337

4a Coyne WE. Cusic JW. J. Med. Chem. 1968, 11: 1158

4b Sanner JH. Arch. Int. Pharmacodyn. Ther. 1969, 180: 46

4c Coleman RA. Kennedy I. Sheldrick RLG. J. Pharmacol. 1987, 91: 323P

4d Lawrence RA. Jones RL. Wilson NH. Br. J. Pharmacol. 1992, 105: 271

4e Drower EJ. Stapelfeld A. Mueller RA. Hammond DL. Eur. J. Pharmacol. 1987, 133: 249

4f Hallinan EA. Hagen TJ. Husa RK. Tsymbalvo S. Rao SN. vanHoeck J.-P. Rafferty MF. Stapelfeld A. Savage MA. Reichman M. J. Med. Chem. 1993, 36: 3293

4g Hallinan EA. Stapelfeld A. Savage MA. Reichman M. Bioorg. Med. Chem. Lett. 1994, 4: 509

4h Hallinan EA. Hagen TJ. Tsymbalov S. Husa RK. Lee AC. Stapelfeld A. Savage MA. J. Med. Chem. 1996, 39: 609

4i Hallinan EA. Hagen TJ. Tsymbalov S. Stapelfeld A. Savage MA. Bioorg. Med. Chem. 2001, 9: 1

For synthesis of indoles, see:

5a Dai W.-M. Guo D.-S. Sun L.-P. Tetrahedron Lett. 2001, 42: 5275

5b Dai W.-M. Sun L.-P. Guo D.-S. Tetrahedron Lett. 2002, 43: 7699

5c Dai W.-M. Guo D.-S. Sun L.-P. Huang X.-H. Org. Lett. 2003, 5: 2919

5d Sun L.-P. Huang X.-H. Dai W.-M. Tetrahedron 2004, 60: 10983

6 For synthesis of benzofuranes, see: Dai W.-M. Lai KW. Tetrahedron Lett. 2002, 43: 9677

For synthesis of 1,4-benzoxazines, see:

7a Dai W.-M. Wang X. Ma C. Tetrahedron 2005, 61: 6879

7b Feng G. Wu J. Dai W.-M. Tetrahedron 2006, 62: 4635

7c Xing X. Wu J. Feng G. Dai W.-M. Tetrahedron 2006, 62: 6774

8a Künzle F. Schmutz J. Helv. Chim. Acta 1969, 52: 622

8b Nagarajan K. Venkateswarlu A. Kulkarni CL. Shah RK. Indian J. Chem. 1974, 12: 227

8c Chakrabarti JK. Hicks TA. Eur. J. Med. Chem. 1987, 22: 161

8d Konstantinova AV. Gerasimova TN. Kozlova MM. Petrenko NI. Chem. Heterocycl. Compd. 1989, 25: 451

8e Samet AV. Marshalkin VN. Kislyi KA. Chernysheva NB. Strelenko YA. Semenov VV. J. Org. Chem. 2005, 70: 9371

For examples of solid-phase synthesis, see:

8f Ouyang X. Tamayo N. Kiselyov AS. Tetrahedron 1999, 55: 2827

8g Hone ND. Salter JI. Reader JC. Tetrahedron Lett. 2003, 44: 8169 ; see also ref. 1a

9 Hagen TJ. Rafferty MF. Collins JT. Garland DJ. Li JJ. Norton MB. Reitz DB. Tsymbalov S. Pitzele BS. Hallinan EA. Heterocycles 1994, 38: 601

10a Multicomponent Reactions Zhu J. Bienaymé H. Wiley; Weinheim: 2005.

10b Gokel G. Lüdke G. Ugi I. In Isonitrile Chemistry Ugi I. Academic Press; New York: 1971.

Selected recent reviews on IMCRs, see:

11a Dömling A. Ugi I. Angew. Chem. Int. Ed. 2000, 39: 3168

11b Weber L. Curr. Med. Chem. 2002, 9: 2085

11c Hulme C. Gore V. Curr. Med. Chem. 2003, 10: 51

11d Zhu J. Eur. J. Org. Chem. 2003, 1133

11e Ramón DJ. Yus M. Angew. Chem. Int. Ed. 2005, 44: 1602

11f Dömling A. Chem. Rev. 2006, 106: 17

12a Tempest P. Ma V. Kelly MG. Jones W. Hulme C. Tetrahedron Lett. 2001, 42: 4963

For selected examples of U-4CR-S_NAr synthesis, see:

12b Tempest P. Pettus L. Gore V. Hulme C. Tetrahedron Lett. 2003, 44: 1947

12c Kalinski C. Umkehrer M. Gonnard S. Jäger N. Ross G. Hiller W. Tetrahedron Lett. 2006, 47: 2041

12d For a recent synthesis of annulated 1,4-oxazepines via Ugi reaction of oxo acids, see: Ilyin AP. Parchinski VZ. Peregudova JN. Trifilenkov AS. Poutsykina EB. Tkachenko SE. Kravchenko DV. Ivachtchenko AV. Tetrahedron Lett. 2006, 47: 2649

For examples of microwave-assisted IMCRs, see:

13a Hoel AML. Nielsen J. Tetrahedron Lett. 1999, 40: 3941

13b Varma RS. Kumar D. Tetrahedron Lett. 1999, 40: 7665

13c Ireland SM. Tye H. Whittaker M. Tetrahedron Lett. 2003, 44: 4369

13d Chen JJ. Deshpande SV. Tetrahedron Lett. 2003, 44: 8873

13e Tye H. Whittaker M. Org. Biomol. Chem. 2004, 2: 813

13f Lu Y. Zhang W. QSAR Comb. Sci. 2004, 23: 827

13g Zhang W. Tempest P. Tetrahedron Lett. 2004, 45: 6757

14

The X-ray crystal data of 3c (excluding structure factors) have been deposited at the Cambridge Crystallographic Data Centre as supplementary publication no CCDC 605469. Copy of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44(1223)336033 or e-mail: deposit@ccdc.cam.ac.uk].

15 Kalinski C. Umkehrer M. Ross G. Kolb J. Burdack C. Hiller W. Tetrahedron Lett. 2006, 47: 3423

16 Poondra RR. Turner NJ. Org. Lett. 2005, 7: 863

17

Selected Spectroscopic Data.
Compound 3c: a white crystalline solid; mp 234-235 °C (EtOAc-hexane). IR (KBr): 3422, 2929, 1647, 1344 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 8.73 (d, J = 2.4 Hz, 1 H), 8.22 (dd, J = 8.4, 2.8 Hz, 1 H), 7.57 (d, J = 7.6 Hz, 1 H), 7.43 (d, J = 8.0 Hz, 1 H), 7.39 (d, J = 7.6 Hz, 1 H), 7.24 (d, J = 8.8 Hz, 1 H), 7.19 (t, J = 7.6 Hz, 1 H), 7.05 (t, J = 7.6 Hz, 1 H), 6.89 (s, 1 H), 6.72 (d, J = 8.0 Hz, 1 H), 6.13 (s, 1 H), 6.01 (br s, 1 H), 3.94-3.86 (m, 1 H), 2.14 (s, 3 H), 2.02-1.93 (m, 2 H), 1.71-1.55 (m, 3 H), 1.40-1.30 (m, 2 H), 1.23-1.12 (m, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 167.8, 165.6, 165.4, 154.4, 145.1, 138.3, 133.7, 133.6, 132.2, 130.5, 129.2, 128.7, 127.5, 127.5, 126.8 (br), 126.1, 121.7, 121.6, 68.3 (br and very weak), 49.4, 33.1, 33.1, 31.2 (for minor atropisomer), 25.8, 25.1, 25.0, 20.9 (two carbons are missing due to atropisomerism). MS (+ESI): m/z (%) = 586 (100) [M + Na⁺]. Anal. Calcd for C₂₈H₂₆BrN₃O₅: C, 59.58; H, 4.64; N, 7.44. Found: C, 59.32; H, 4.63; N, 7.56.
Compound 4a: a white crystalline solid; mp 171-174 °C (EtOAc-hexane); R _f = 0.25 (17% EtOAc in hexane). IR (KBr): 3280, 2929, 1654, 1522, 1345, 1266 cm^-1. ¹H NMR (400 MHz, CDCl₃): δ = 8.18 (dd, J = 8.8, 2.4 Hz, 1 H), 8.11 (d, J = 2.8 Hz, 1 H), 7.47 (d, J = 7.6 Hz, 2 H), 7.40 (d, J = 8.8 Hz, 1 H), 7.36 (t, J = 7.6 Hz, 1 H), 7.27-7.23 (m, 2 H), 7.16 (d, J = 8.4 Hz, 1 H), 6.98 (d, J = 8.0 Hz, 1 H), 6.76 (s, 1 H), 6.40 (s, 1 H), 6.28 (br d, J = 8.0 Hz, 1 H), 3.70-3.60 (m, 1 H), 1.94 (s, 3 H), 1.88-1.84 (m, 1 H), 1.80-1.50 (m, 4 H), 1.40-1.08 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 171.3, 166.3, 158.8, 148.9, 142.7, 135.3, 133.4, 131.5, 131.4, 130.1 (x2), 129.9 (x2), 128.9, 128.2, 127.5, 124.6, 123.8, 122.1, 121.2, 61.3, 48.4, 33.2, 32.7, 25.3, 24.6, 20.4. MS (+ESI): m/z (%) = 508 (100) [M + Na⁺], 486 (14) [M + H⁺]. Anal. Calcd for C₂₈H₂₇N₃O₅: C, 69.26; H, 5.61; N, 8.65. Found: C, 69.28; H, 5.65; N, 8.65.
Compound 5c: a white crystalline solid; mp 222-224 °C. IR (KBr): 3448, 2924, 1654, 1348 cm^-1. ¹H NMR (500 MHz, DMSO-d ₆, 80 °C): δ = 8.42 (br s, 1 H), 8.37 (dd, J = 9.0, 3.0 Hz, 1 H), 7.59 (d, J = 9.0 Hz, 1 H), 7.30-7.26 (m, 4 H), 7.18 (d, J = 8.0 Hz, 1 H), 7.08 (br s, 1 H), 6.99 (t, J = 8.0 Hz, 1 H), 5.90-5.60 (br s, 1 H), 4.14-4.08 (m, 1 H), 2.31 (s, 3 H), 2.29-2.09 (m, 2 H), 1.89-1.70 (m, 5 H), 1.46-1.24 (m, 3 H). ¹³C NMR (125 MHz, DMSO-d ₆, 80 °C): δ = 172.0, 164.3, 162.8 (br and weak), 152.5, 144.8, 143.2, 137.8, 131.4 (br and weak), 128.9, 128.7, 127.5, 127.5, 126.2, 125.5, 123.5 (br), 123.1 (br), 122.0, 121.8, 121.7, 109.8, 62.8 (br and weak), 52.6, 28.7, 28.4, 25.6, 25.0, 20.1. MS (+ESI): m/z 506 (100) [M + Na⁺]. Anal. Calcd for C₂₈H₂₅N₃O₅: C, 69.55; H, 5.21; N, 8.69. Found: C, 69.55; H, 5.23; N, 8.69.